Status:
COMPLETED
Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis
Lead Sponsor:
Maulana Azad Medical College
Conditions:
Pulmonary Tuberculosis
Eligibility:
All Genders
10-70 years
Brief Summary
N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) are two drug metabolizing enzymes. Antituberculosis drug isoniazid is acetylated by NAT2 and forms ultimately a nontoxic compound which is m...
Eligibility Criteria
Inclusion
- Patients with pulmonary tuberculosis
- Patients receiving conventional antituberculosis drugs
- Patients who directly presented with antituberculosis drug induced hepatitis
Exclusion
- Habitual alcohol drinkers
- Patients with evidence of viral hepatitis
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
End Date :
September 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00834353
Start Date
September 1 2005
End Date
September 1 2008
Last Update
February 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Premashis Kar
New Delhi, New Delhi, India, 110002